Cambodia
Diabetes country report 2011 — 2050
Number of adults (20–79 years) with diabetes in Cambodia (KH)
2011 | 199.4 thousand |
2024 | 723.2 thousand |
2050 | 1.2 million |
Cambodia is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- Wagner J, Naranjo D, Khun T, Seng S, Horn I, Suttiratana S et al. J Diabetes 2018, 10 (2), 148-157. DOI: 10.1111/1753-0407.12570. PMID: 28544429
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 199.4 | 723.2 | 1,163.4 |
Age-standardised prevalence of diabetes, % | - | 2.9 | 7.5 | 8.7 |
Proportion of people with undiagnosed diabetes, % | - | - | 50.0 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 361.3 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 727.1 | 1,048.0 |
Age-standardised prevalence of IFG, % | - | - | 7.0 | 7.6 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 720.2 | 755.0 | 1,106.8 |
Age-standardised prevalence of IGT, % | - | 9.7 | 7.3 | 8.1 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 4,895.0 | 4,983.4 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 6.3 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 170.9 | 250.5 |
Total diabetes-related health expenditure, ID million | - | - | 493.0 | 722.4 |
Diabetes-related health expenditure per person, USD | - | 82.0 | 236.4 | 215.3 |
Diabetes-related health expenditure per person, ID | - | - | 681.7 | 620.9 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 582.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 231.9 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 8,079.6 | 10,632.1 | 13,972.3 |
Population of children and adolescents (0-19 y) | - | - | 6,886,274.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |